BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to SCC-9 cell line is 38
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-9 | NA | Western Blotting followed by CFA | NA | 0.28 | 0.5695 | 34837170 |
| MIR147B | 33655 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 26323893 |
| MIR147B | 33655 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 26323893 |
| MIR1976 | 37064 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 26323893 |
| MIR1976 | 37064 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 26323893 |
| MIR3622A | 38934 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0011 | 26323893 |
| MIR3622A | 38934 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0011 | 26323893 |
| MIR424 | 31881 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0064 | 26323893 |
| MIR424 | 31881 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0064 | 26323893 |
| MIR4730 | 41880 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 26323893 |
| MIR4730 | 41880 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 26323893 |
| MIR6836 | 50067 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 26323893 |
| MIR6836 | 50067 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 26323893 |
| MIR6873 | 50231 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 26323893 |
| MIR6873 | 50231 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 26323893 |
| MIR7152 | 50257 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 26323893 |
| MIR7152 | 50257 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 26323893 |
| MIRLET7A1 | 31476 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0032 | 26323893 |
| MIRLET7A1 | 31476 | HTM/LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | FACs for CSC marker and SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0032 | 26323893 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-9 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 26323460 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.5461 | 26323893 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.5461 | 26323893 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | SFA followed by qPCR | NA | 0.2 | 0.5461 | 21304586 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-9 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 26323460 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.6448 | 26323893 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.6448 | 26323893 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | SFA followed by qPCR | NA | 0.2 | 0.6448 | 21304586 |
| SNAI1 | 11128 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-9 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0212 | 26323460 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-9 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 26323460 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.5695 | 26323893 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.5695 | 26323893 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | SFA followed by qPCR | NA | 0.2 | 0.5695 | 21304586 |
| TWIST1 | 12428 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-9 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0191 | 26323460 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | ALDEFLUOR assay followed by SFA and Tumorigenicity assay | NA | 0.12 | 0.684 | 26323893 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 21304586 |
| ALDH1A2 | 15472 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | ALDEFLUOR assay followed by SFA and Tumorigenicity assay | NA | 0.12 | 0.0117 | 26323893 |
| CD24 | 1645 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | SFA followed by FACs | NA | 0.12 | 0.456 | 21304586 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UT-SCC-9 | NA | SFA followed by FACs | NA | 0.12 | 1 | 21304586 |